Substrate
Topic

targeted-drug-delivery

1 stories related to this topic, newest first.

Patient Reports Symptom Improvement in Phase III Trial of Experimental Targeted Chemotherapy for Pancreatic CancerFox News
technology15 days agoDeveloping

Patient Reports Symptom Improvement in Phase III Trial of Experimental Targeted Chemotherapy for Pancreatic Cancer

Hernando Salcedo, 83, experienced fewer side effects and regained energy after eight TAMP sessions delivered via RenovoRx's RenovoCath device at Miami Cancer Institute. Early TIGeR-PaC trial data showed trends toward better survival and 65% fewer adverse events. Enrollment is exp…

Fox News
1 source